Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.76 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.53 |
| ▸ | ENPP2 | Q13822 | 10/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 7/20 | 0.50 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18327147 | 1.00 | ALDH1A1 (0.76) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 | |
| SCHEMBL9234695 | 1.00 | ALDH1A1 (0.76) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 | |
| SCHEMBL5839131 | 1.00 | ALDH1A1 (0.76) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 | |
| SCHEMBL9234691 | 1.00 | ALDH1A1 (0.76) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 | |
| SCHEMBL10770166 | 1.00 | ALDH1A1 (0.76) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 | |
| SCHEMBL18327140 | 1.00 | ALDH1A1 (0.76) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 | |
| SCHEMBL30958398 | 1.00 | ALDH1A1 (0.76) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 | |
| SCHEMBL18327149 | 0.94 | ALDH1A1 (0.68) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 | |
| SCHEMBL899230 | 0.94 | ALDH1A1 (0.68) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 | |
| SCHEMBL899229 | 0.94 | ALDH1A1 (0.68) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7112706-B2 | Dimerdiol derivatives and composition of matter including the dimerdiol derivatives | CRODA JAPAN KK (JP) | 2006-09-26 | — | — | US | claimed |
| US-20030225223-A1 | Dimerdiol derivatives and composition of matter including the dimerdiol derivatives | CRODA JAPAN KK (JP) | 2003-12-04 | — | — | US | claimed |
| US-7112706-B2 | Dimerdiol derivatives and composition of matter including the dimerdiol derivatives | CRODA JAPAN KK (JP) | 2006-09-26 | — | — | US | disclosed |
| US-20030225223-A1 | Dimerdiol derivatives and composition of matter including the dimerdiol derivatives | CRODA JAPAN KK (JP) | 2003-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225223-A1 | Dimerdiol derivatives and composition of matter including the dimerdiol derivatives | DHCR24, DRD1, CTNND1 | ALDH1A1 203/4885EPHX1 1054/4885ENPP2 3078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.